• 1
    Penn I. Cancer is a complication of severe immunosuppression. Surg Gynecol Obstet 1986; 162:603.
  • 2
    Penn I. Occurrence of cancer in immune deficiencies, Cancer, 1974; 34, suppl: 858.
  • 3
    Porreco R, Penn I, Droegemueller W, Greer B, Makowski E. Gynecologic malignancies in immunosuppressed organ homograft recipients. Obstet Gynecol 1975; 45:359.
  • 4
    Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348:1681.
  • 5
    Fairkey CK, Sheil AG, McNeil JJ, Ugoni AM, Disney AP, Giles GG, et al. The risk of ano-genital malignancies in dialysis and trasnplant patients. Clin Nephrol 1994; 41:101.
  • 6
    Müller H, Petritsch P, Wirnsberger G, Holzer H, Tscheliessnigg K. Renal Transplantation. Eur Surg 2003; 35:315.
  • 7
    Melbye M, Rabkin C, Frisch M, Biggar RJ. Changing patterns of anal cancer incidence in the United States, 1940–1989. Am J Epidemiol 1994; 139:772.
  • 8
    Frisch M, Melbye M, Moller H. Trends in incidence of anal cancer in Denmark. BMJ 1993; 306:419.
  • 9
    Beutner KR, Tyring S. Human papillomavirus and human disease. Am J Med 1997; 102:9.
  • 10
    Schiffman M, Herrero R, Hildesheim A, Sherman ME, Bratti M, Wacholder S, et al. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA 2000; 283:87.
  • 11
    Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997; 102:3.
  • 12
    Kirnbauer R, Hubbert NL, Wheeler CM, Becker TM, Lowy DR, Schiller JT. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst 1994; 86:494.
  • 13
    Mathews WC. Screening for anal dysplasia associated with human papillomavirus. Top HIV Med 2003; 11:45.
  • 14
    Palefsky JM, Holly EA, Ralston ML, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 1998; 177:361.
  • 15
    Palefsky JM, Holly EA, Ralston ML, Jay N, Berry JM, Darragh TM. High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS 1998; 12:495.
  • 16
    Ogunbiyi OA, Scholefield JH, Raftery AT, Smith JH, Duffy S, Sharp F, et al. Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients. Br J Surg 1994; 81:365.
  • 17
    Horl WH. Neutrophil function and infections in uremia. Am J Kidney Dis 1999; 33:xlv.
  • 18
    Bahr MJ, Manns MP. Funktion des Immunsystems bei Leberzirrhose. Z Gastroenterol 2001; 39:601.
  • 19
    Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Palefsky JM. Costeffectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men. Am J Med 2000; 108:634.
  • 20
    Gravitt PE, Burk RD, Lorincz A, Herrero R, Hildesheim A, Sherman ME, et al. A comparison between realtime polymerase chain reaction and hyhrid capture 2 for human papillomavirus DNA quantitation. Cancer Epidemiol Biomarkers Prev 2003; 12:477.
  • 21
    Kirnbauer R, Taub J, Greenstone H, Roden R, Durst M, Gissmann L, et al. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J Virol 1993; 67:6929.
  • 22
    Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002; 347:1645.